Minaris Advanced Therapies
Christopher (CJ) Blasi is an experienced professional in the field of cell therapy and regenerative medicine, currently serving as Associate Operations Manager at Minaris Regenerative Medicine since June 2017. Prior roles include Operations Supervisor and various levels of Cell Therapy Associate, with expertise in CAR-T manufacturing processes, CRISPR-Cas9 technology, and technology transfers from Process Development to Manufacturing. Previous experience includes undergraduate research at Bucknell University, where testing on viral genomes was conducted, and a research assistantship at the University of Sydney focused on disease modeling. Additional research experience includes conducting field studies in Australia, an internship at Whitehouse Laboratories working on quality control of pharmaceutical products, and participation in the Phage Hunters program at Bucknell University. Christopher holds a Bachelor's Degree in Biology with an emphasis on Computer Science from Bucknell University.
This person is not in any teams
This person is not in any offices
Minaris Advanced Therapies
1 followers
Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 730,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. Minaris Advanced Therapies is wholly owned by Altaris, LLC.